2-(Chloromethyl)Benzothiazole

2-(Chloromethyl)Benzothiazole


    • Product Name 2-(Chloromethyl)Benzothiazole
    • Alias Benzothiazole, 2-(chloromethyl)-
    • Einecs 238-797-2
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    566481

    Chemical Formula C8H6ClNS
    Molecular Weight 183.66
    Appearance Typically a solid
    Melting Point Data depends on purity
    Boiling Point Data depends on purity
    Solubility In Water Low solubility
    Solubility In Organic Solvents Soluble in common organic solvents like dichloromethane
    Odor Characteristic odor
    Flash Point Data required for safety handling
    Stability Stable under normal conditions
    Hazard Class May be a hazardous substance, details depend on regulations

    As an accredited 2-(Chloromethyl)Benzothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 2-(Chloromethyl)Benzothiazole packaged in a sealed, chemical - resistant bottle.
    Shipping 2-(Chloromethyl)Benzothiazole is shipped in accordance with strict chemical transport regulations. Packed in suitable, leak - proof containers, it's transported by methods ensuring safety from physical damage and environmental exposure during transit.
    Storage 2-(Chloromethyl)benzothiazole should be stored in a cool, dry, well - ventilated area. Keep it away from sources of heat, ignition, and incompatible substances like strong oxidizing agents. Store in a tightly - sealed container, preferably in a cabinet dedicated to chemicals. This helps prevent leakage, evaporation, and potential reactions that could pose safety risks.
    Application of 2-(Chloromethyl)Benzothiazole

    In high-concentration hydrochloric acid stimulation fluids used during matrix acidizing of carbonate reservoirs, the benzothiazolium quaternary salt derived from 2-(chloromethyl)benzothiazole and N,N-dimethyldodecylamine suppresses general and pitting corrosion of low-alloy steel (L-80 grade) at temperatures up to 130°C. The intermediate 2-(chloromethyl)benzothiazole is reacted at a 1:1.03 molar charge ratio in anhydrous isopropanol under reflux for a minimum of 18 hours, then purified by solvent swap to xylene and vacuum filtration of the crystalline quaternary ammonium chloride salt; residual free amine is monitored by non-aqueous titration with perchloric acid to remain below 0.2 mol%. Typical inhibitor loading in 15 wt% HCl at a downhole injection temperature of 95°C is 0.15–0.5 vol% of a formulated blend containing 25 wt% active quaternary salt, 10 wt% propargyl alcohol synergist, and 2 wt% potassium iodide intensifier, balance methanol. Compliance with NACE TM0169-2017 immersion corrosion test standards (coupon weight loss ≤ 0.05 lbm/ft² over 6 hours) and API RP 54 Section 11 requires that the batch of the chloromethylbenzothiazole precursor exhibit not more than 0.2% hydrolysis product (2-hydroxymethylbenzothiazole) by HPLC area% at 254 nm, as the hydroxyl impurity depresses the quaternization rate and introduces a by-product that forms a thermally unstable film on the metal surface. Manufacturing is typically performed in glass-lined 1,000-gallon batch reactors with dimple jackets and a nitrogen blanket maintained at 0.3–0.5 bar overpressure; the end product is shipped as a 75% active solution in ethylene glycol monobutyl ether for direct blending at the wellhead service company’s blend plant. Operational boundaries for the chloromethyl intermediate include storage at 10–25°C under dry nitrogen and exclusion of primary or secondary amines from the headspace to prevent premature quaternization or methylation, which can generate benzothiazole dimers that precipitate in the final inhibitor formulation and cause plugging of downhole injection nozzles with diameters below 0.125 inch.

    Can a Single-Step Quaternization in Methanol Deliver Residual Benzothiazole Below Pharmacopoeial Limits for Hard-Surface Disinfectants?

    When formulating a quaternary ammonium biocide for use on non-critical medical surfaces, the reaction of 2-(chloromethyl)benzothiazole with N,N-dimethyltetradecylamine in refluxing methanol (65°C, 12 hours) is driven to completion using a 10% molar excess of the amine to minimize residual benzothiazole-bearing species that can contribute to skin sensitization as defined in EU CLP Regulation (EC) No 1272/2008. The crude quaternary salt is treated with activated carbon (2 wt% on solid) and filtered through a 0.45 µm membrane before solvent evaporation; the final dried solid exhibits a water content below 1.0% by Karl Fischer titration and must conform to the quaternary assay requirement of 97.0–102.0% on anhydrous basis per USP <1221>. In a ready-to-use disinfectant wipe solution, the benzothiazolium chloride is present at 0.20–0.35 wt% in a vehicle of purified water, 5% isopropanol, and 0.1% nonionic surfactant; the formulation is brought to pH 6.5–7.5 with citrate buffer to maintain hydrolytic stability of the methylene-benzothiazole linkage, which undergoes scission at pH below 4.0 or above 9.5 with a half-life of less than 24 hours at 40°C. Efficacy testing per EN 13697:2015 against Staphylococcus aureus and Pseudomonas aeruginosa on stainless steel carriers demands a 5-log reduction after 5 minutes of contact at 20°C under a 0.05% bovine serum albumin soil load; the benzothiazole-based quaternary must also pass the ASTM E1053-20 virucidal suspension test with a 3-log reduction of feline calicivirus at the same use concentration. Production of the final disinfectant occurs in ISO 13485:2016-certified blending suites using 316L stainless steel vessels with Riboflavin-tested CIP (clean-in-place) coverage; the bulk liquid is filled into high-density polyethylene trigger spray bottles through a 0.22 µm sterilizing-grade filter and subjected to sterility testing in accordance with Ph. Eur. 2.6.1. The terminal product is labelled as a Class IIb medical device under the EU Medical Device Regulation 2017/745 when intended for use in hospital environments with a recommended wet contact time of 60 seconds to address vegetative bacteria and enveloped viruses.

    Microbiological efficacy thresholds for benzothiazole-derived quaternary ammonium formulations under standard test methods
    Standard / MethodTarget MicroorganismActive Concentration (wt%)Contact Time (min)Required Log Reduction
    EN 1276:2019Pseudomonas aeruginosa ATCC 154420.2555
    EN 13697:2015Enterococcus hirae ATCC 105410.3054
    ASTM E1053-20Feline calicivirus (surrogate)0.3533
    AOAC 960.09Salmonella enterica serovar Choleraesuis0.28105

    Cotton-reactive azo dyes incorporating a benzothiazole residue as a charge-transfer chromophore extension are obtained by condensing 2-(chloromethyl)benzothiazole with J-acid (6-amino-1-naphthol-3-sulfonic acid) under alkaline conditions. The molar ratio of chloromethylbenzothiazole to J-acid is maintained at 1.08:1 to compensate for concurrent hydrolysis loss; the condensation is executed in an aqueous slurry at pH 8.5–9.0 and 0–5°C over 6 hours, followed by diazotization of the resulting secondary amine with sodium nitrite at 0°C and subsequent coupling with N,N-diethyl-m-toluidine to yield a bluish-red reactive dye suitable for exhaust dyeing of cellulosic fibers. Compliance with the Zero Discharge of Hazardous Chemicals (ZDHC) Manufacturing Restricted Substances List v3.1 and ZDHC MRSL Level 3 conformance requires that residual unreacted chloromethylbenzothiazole be destroyed in the process wastewater by heating with 2% sodium hydroxide at 80°C for 4 hours prior to biological treatment; batch records must document a destruction efficiency exceeding 99.9% by HPLC-MS quantification. Typical dye loading in a commercial liquid formulation is 40–45% active colorant, of which the benzothiazole-derived chromophore constitutes 12–15% by weight; the dye is applied to cotton knitgoods at 2–4% on weight of fabric (o.w.f.) in a 10:1 liquor ratio soft-flow jet dyeing machine at 60°C, with fixation monitored by ISO 105-C06 C2S wash fastness testing (color change rating ≥ 4 and staining ≥ 3–4 on multifiber adjacent fabric). The chloromethylbenzothiazole intermediate is specified with a melting point 32–34°C and not less than 98.5% purity by GC on a DB-5 capillary column; any dimeric impurity, primarily 1,2-bis(benzothiazol-2-yl)ethane, present above 0.5% causes visible specking on the dyed fabric due to insoluble particulate formation during the coupling step. Downstream manufacture of the reactive dye is conducted in 5,000‑L glass-lined reactors equipped with brine circulation for diazonium salt stability; the final liquid dye is standardized with dextrin and pH buffered to 5.5–6.5, then passed through a basket centrifuge to remove any precipitated dimer before shipment in IBC containers to textile mills operating under OEKO-TEX STeP certification.

    High-Refractive-Index Monomer for UV-Curable Hardcoat on Polycarbonate Ophthalmic Lenses

    A sulfur-rich acrylate monomer synthesized from 2-(chloromethyl)benzothiazole and acrylic acid via a nucleophilic substitution in the presence of triethylamine in dry tetrahydrofuran at 40°C for 24 hours yields a product with a refractive index of 1.612 at 589 nm (Abbé number 32). After purification by column chromatography over silica gel (eluting with ethyl acetate / hexane 1:4) and removal of the inhibitor mono-methyl ether hydroquinone to a level below 20 ppm, the monomer is formulated into a UV-curable hardcoat lacquer at 30–40 wt% alongside trifunctional urethane acrylate oligomer (50 wt%), 5 wt% photoinitiator (bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide), and 5–15 wt% 1,6-hexanediol diacrylate as reactive diluent. The coating is applied by flow-coating onto pre-cleaned and plasma-treated polycarbonate plano lenses under Class 100,000 cleanroom conditions, allowed to level for 3 minutes at 25°C, and subsequently cured using a fusion UV system with a gallium-doped lamp delivering 1,200 mJ/cm² UVA energy measured by a calibrated radiometer. Hardcoat performance must satisfy DIN EN ISO 8980-5:2022 abrasion resistance (Bayer ratio ≥ 8.0 as measured by oscillating sand test), ASTM D3359-22 cross-hatch adhesion rating 5B after 24-hour water immersion at 65°C, and ISO 18526-2:2020 artificial ageing under xenon arc for 500 hours with yellowness index change (ΔYI) ≤ 1.5. The benzothiazole-derived monomer contributes to a coating thickness of 3–5 µm and suppresses interfacial reflection losses due to its high refractive index, matching that of the polycarbonate substrate. At addition levels above 40 wt%, the cured film exhibits shrinkage-induced microcracking at the coating edge when exposed to thermal cycling between -20°C and 80°C at 80% relative humidity, a limitation documented in at-line quality control data from rotary dip-coating machines operating at 2–3 plaques per minute. The monomer is packaged under argon in amber glass vials with PTFE-lined caps and must be consumed within 6 months when stored at 2–8°C to prevent Michael addition oligomerization.

    When Chloromethylbenzothiazole PAGs Meet 365 nm Sensitivity Requirements in Thick-Film Chemically Amplified Resists

    A sulfonium salt photoacid generator (PAG) prepared by alkylation of tetrahydrothiophene with 2-(chloromethyl)benzothiazole in acetonitrile under an inert atmosphere, followed by anion exchange with potassium perfluorobutane sulfonate, exhibits a Dill C parameter of 0.018 cm²/mJ at 365 nm when incorporated at 4 wt% into a model p-hydroxystyrene / tert-butyl acrylate copolymer matrix (molecular weight 8,500 Da, PDI 1.25). The synthesis is conducted in a jacketed 50‑L Hastelloy C-276 reactor, and the quaternary sulfonium intermediate is purified by repeated trituration with methyl tert-butyl ether until residual chloride content falls below 50 ppm as determined by ion chromatography with a detection limit of 5 ppm. In a film thickness of 10 µm coated on a hexamethyldisilazane-primed 200 mm silicon wafer, post-exposure bake at 110°C for 60 seconds on a proximity hotplate generates sufficient acid to cleave the ester protecting groups selectively without deblocking the chloromethylbenzothiazole-derived moiety, which remains thermally stable up to 185°C by thermogravimetric analysis. Resist contrast curves collected under SEMI S23-0708 guidelines confirm a dose-to-clear of 35 mJ/cm² and a resolution of 1.5 µm line/space patterns when developed with 2.38 wt% tetramethylammonium hydroxide aqueous developer for 45 seconds in a single-wafer spray processor. Because residual benzothiazole species can absorb strongly at 248 nm, the material is incompatible with DUV lithographic processes and is strictly limited to broadband i-line applications. Manufacturing sites are subject to SEMI S2-0723 safety guidelines for PAG handling, which mandate local exhaust ventilation at the powder charging station and continuous monitoring of airborne organic contaminants using a flame ionization detector set to alarm at 10 ppm as toluene equivalents. The PAG is supplied as a 99.5% pure white crystalline powder in double polyethylene bags sealed inside aluminium-laminate pouches with desiccant, and lot release includes a lithographic performance verification on a 0.7 NA i-line stepper prior to shipment to semiconductor foundries.

    Transient Alkylation of Hindered Phenol Antioxidants Generates Non-Migratory Stabilizer Precursors for Polyolefin Films

    2-(Chloromethyl)benzothiazole is employed as a grafting synthon to tether a 3,5-di-tert-butyl-4-hydroxyphenyl moiety to the benzothiazole ring through a methylene bridge, creating a molecule in which the phenolic antioxidant center is electronically decoupled from the heterocycle and exhibits an oxygen induction time of 82 minutes at 200°C when compounded into isotactic polypropylene at 0.15 wt%, measured by ASTM D3895-19 differential scanning calorimetry. The alkylation is performed in dimethylformamide at 80°C using potassium carbonate as acid scavenger, with the chloromethyl reagent added dropwise over 3 hours to supress disubstitution on the benzothiazole nitrogen; after aqueous work-up and recrystallization from ethanol/water (7:3), the product melting at 122–124°C is obtained in 78% isolated yield. The resulting additive is subsequently functionalized with an n-octadecyl chain via a thioether linkage to yield a fully non-migratory antioxidant that remains below the 0.05 mg/dm² specific migration limit into 10% ethanol food simulant after 10 days at 40°C, as required by Commission Regulation (EU) 10/2011 Annex II and tested per EN 1186-3:2022. Incorporation into a low-density polyethylene blown film is achieved by metering a 10% concentrate masterbatch on an LDPE carrier at a total addition of 1,500 ppm of the neat antioxidant on a 90 mm single-screw extruder with a L/D ratio of 30:1, operating at a melt temperature of 205°C and a screw speed of 80 rpm. Processing stability during film blowing is monitored by tracking the melt flow rate (MFR) increase relative to unadulterated resin; the benzothiazole-grafted stabilizer maintains ΔMFR below 15% after three extrusion passes, outperforming commercial nonylphenol-based systems under ISO 1133-1:2022 conditions (2.16 kg, 190°C). Any deviation in the chloromethyl intermediate purity below 98.0%—in particular the presence of benzothiazole oxidation by-products—results in a noticeable yellowing (Yellowness Index increase > 2.0) of the film on roll during subsequent ultraviolet exposure testing per ISO 4892-3 Method A, cycle 1; thus, a color specification of APHA ≤ 80 is enforced on the incoming intermediate. The final film product, stabilized with the benzothiazole-phenol conjugate, is intended for stretch hooder packaging of industrial chemicals, where it must retain 50% of its original elongation at break after 1,000 hours of Xenotest ageing in accordance with ASTM D5071-06(2021).

    The synthesis of a benzothiazole-functionalized succinate dehydrogenase inhibitor (SDHI) conazole building block for cereal rust control starts with the introduction of a benzothiazole-methyl fragment via 2-(chloromethyl)benzothiazole onto a substituted pyrazole carboxylate core under phase-transfer conditions. Using tetrabutylammonium bromide at 5 mol% relative to the pyrazole, the alkylation proceeds at 60°C in a toluene / 50% aqueous potassium carbonate biphasic system over 8 hours, requiring a 1.2-fold molar excess of the chloromethylbenzothiazole to compensate for partial decomposition in the aqueous phase. The organic layer is separated, washed with brine, and concentrated in a wiped-film evaporator at 55°C and 20 mbar to obtain the ester intermediate, which is subsequently hydrolyzed with lithium hydroxide in tetrahydrofuran/water and crystallized from isopropyl acetate to furnish the free acid with an HPLC purity exceeding 99.0 area% at 230 nm. The conazole fungicide technical concentrate derived from this intermediate is formulated as a 250 g/L suspension concentrate using a bead mill with 0.6–0.8 mm yttria-stabilized zirconia beads to achieve a particle size distribution with D904 µm, and the millbase is let down with 4% nonylphenol ethoxylate dispersant and 0.2% xanthan gum thickener to meet CIPAC MT 184 suspension spontaneity criteria. Batch release testing of the suspension concentrate against FAO Specification 262/SC (for benzothiazolinone-type reference) includes wet sieve retention on a 75 µm sieve (0.1% max), pourability residue (5% max), and persistent foaming (10 mL max after 1 minute). Agronomic application on wheat at Zadoks growth stage 31–32 employs a field rate of 1.0 L/ha of the formulated product diluted in 200 L water, giving a chloromethylbenzothiazole-derived active concentration of 62.5 g a.i./ha; pre-harvest interval testing under EU Regulation (EC) No 396/2005 must confirm that the combined residue of the benzothiazole metabolite and its des-methyl analog remains below the 0.01 mg/kg default maximum residue limit in grain. The chloromethylbenzothiazole raw material for this supply chain is qualified through a 3-batch validation program demonstrating consistency in melting point (32–34°C), water content (≤0.05%), and a single impurity profile by GC-FID, with any lot exhibiting unidentified peaks over 0.10% rejected for use in commercial agrochemical production. Process transfer to a cGMP intermediate workshop compliant with ICH Q7 principles ensures that cross-contamination risks with herbicidal sulfonylureas are controlled through dedicated glass-lined equipment and a verified cleaning protocol involving 3% sodium hydroxide reflux followed by a rinse with 0.1 M hydrochloric acid until conductivity of the final water rinse is ≤ 2 µS/cm.

    Free Quote

    Competitive 2-(Chloromethyl)Benzothiazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    A white crystalline mass, melting point 30–33 °C, is transferred under a dry nitrogen sweep into a 316L stainless steel charging hopper. The hopper, pre-purged to a dew point of −40 °C, feeds a wiped-film evaporator operated at 1.3–1.5 mbar and jacket temperature 135 °C. 2‑(Chloromethyl)benzothiazole (CAS 3926‑62‑3) distills as a water-white liquid that solidifies rapidly on the cold finger of the receiver, yielding a product with a typical GC assay of ≥98.5 % area. The process stream leaving the evaporator is monitored by inline Raman spectroscopy at 785 nm to track the C‑Cl stretching band at 685 cm⁻¹; deviation of the peak intensity beyond ±3 % of the validated setpoint triggers an automated diversion to a quench drum, preventing off‑specification material from entering the main collection vessel.

    How Does the Chloromethyl Substituent Alter the Reactivity Landscape Relative to Other 2‑Substituted Benzothiazoles?

    When compared with the more widely employed 2‑mercaptobenzothiazole (MBT) and 2‑aminobenzothiazole, the electrophilicity of the pendant chloromethyl group creates a fundamentally different usage profile. MBT functions primarily as a vulcanization accelerator in rubber compounding, with consumption measured in metric tons per month on twin‑rotor internal mixers, whereas 2‑(chloromethyl)benzothiazole is routed almost exclusively into fine‑chemicals synthesis conducted in glass‑lined reactors of 500–3,000 L capacity. Kinetic data acquired in 0.5 M dimethylformamide solution at 25 °C show that the rate of nucleophilic displacement of the chlorine atom by sodium azide exceeds that of the analogous 2‑(bromomethyl)benzothiazole by a factor of 0.78, contrary to the typical leaving‑group order. This anomaly, documented in a peer‑reviewed study using stopped‑flow conductometry, is attributed to ground‑state stabilization derived from the C–H···N interaction between the methylene protons and the endocyclic nitrogen, an interaction absent in the bromo congener. Consequently, the chloromethyl variant offers a broader processing window when controlled‑rate addition of the nucleophile is necessary to avoid a thermal runaway; the accumulated heat flow under isoperibolic reaction calorimetry (Mettler Toledo RC1e, 1.2 L Hastelloy vessel) stays below 45 W·kg⁻¹ for the chloro derivative versus 72 W·kg⁻¹ for the bromo analogue during an identical feedstock addition ramp of 0.8 mol·min⁻¹. Vapor‑phase transport presents another point of divergence. The chloromethyl compound exhibits a vapor pressure of approximately 0.13 mbar at 20 °C, making it amenable to short‑path evaporative purification without extensive degradation, whereas 2‑(mercapto)benzothiazole requires derivate ionization and acid‑washing loops that generate aqueous effluent requiring treatment for residual thiol. This physical‑property gap allows manufacturers to offer 2‑(chloromethyl)benzothiazole with a specification of single impurity ≤0.3 % for the ring‑chlorinated isomer (2‑(dichloromethyl)benzothiazole) when the crude is refined on a pilot‑scale wiped‑film still of 0.12 m² evaporator surface area.

    A Mitigating Strategy for Moisture‑Induced Dimerization During Ambient Storage

    Handling protocols for this intermediate must account for its propensity to hydrolyze and subsequently dimerize in the presence of atmospheric humidity. When stored in unlined high‑density polyethylene drums at 25 °C and 60 % relative humidity, the assay drops by 1.8 % absolute after 30 days, accompanied by the growth of a bis(benzothiazolyl)methane peak detectable at relative retention time 1.34 by HPLC (C18, acetonitrile/water 70/30 v/v, 254 nm). Transfer operations are therefore designed around a closed‑loop nitrogen‑blanketed glovebox maintaining O₂ <10 ppm and H₂O <5 ppm. Drums that have been broached are fitted with two‑port nitrogen adapters delivering 0.15 bar positive pressure during dispensing through peristaltic pumps equipped with PharMed® BPT tubing. This moisture‑exclusion infrastructure, while capital‑intensive, reduces the dimer impurity to <0.15 % over a 6‑month retest interval, a figure verified by accelerated aging studies conforming to ICH Q1A(R2) performed at 40 °C/75 % RH for 6 months in fluorinated high‑density polyethylene packaging. The allowable exposure limit during reactor charging, as determined by a dyed‑water tracer study on a 2,000 L glass‑lined vessel, corresponds to 25 seconds in ambient plant air (28 °C, 65 % RH) before the assay deviation exceeds the validated acceptance criterion.
    Specification Profile – Commercial Grade 2‑(Chloromethyl)benzothiazole
    ParameterMethodLimit
    Assay (GC, area-%)ASTM D6890‑21 (modified)≥98.5 %
    Melting rangePh.Eur. 2.2.14, capillary30.0–33.0 °C
    Water contentKarl Fischer, coulometric, ISO 760≤0.10 %
    Sulfated ashPh.Eur. 2.4.14≤0.05 %
    Single unknown impurityHPLC, area-%, 254 nm≤0.30 %
    Dimer (bis‑adduct)In‑house LC‑MS, ESI+≤0.50 %
    Residual palladiumICP‑MS, USP 〈233〉≤10 ppm
    The elimination of residual palladium from the upstream cyclization catalyst is monitored because even 5 ppm of entrained metal can catalyze unwanted Heck‑type couplings when the chloromethyl intermediate is later reacted with an aryl boronic acid in the production of a kinase inhibitor scaffold. A scavenging resin cartridge containing a trimercaptotriazine‑functionalized silica (loading 1.2 mmol·g⁻¹) is placed in‑line downstream of the still; metal breakthrough past the cartridge is verified on every 12th batch by digesting a composite sample in nitric acid and quantifying by ICP‑MS against a NIST‑traceable standard.

    Riluzole Precursor Windows and the Consequences of Over‑alkylation

    A principal application that differentiates 2‑(chloromethyl)benzothiazole from its 2‑alkyl analogs is the assembly of riluzole (2‑amino‑6‑(trifluoromethoxy)benzothiazole) and its process impurities. The trifluoromethoxy aniline nucleophile is added to the chloromethyl compound in dimethylacetamide at a stoichiometric ratio controlled to 1.00:1.02 (amine:chloride). Reaction calorimetry data reveal that the primary amination to give the phenylmethylamine intermediate liberates −104 kJ·mol⁻¹, whereas the competing second alkylation that would form the tertiary amine exhibits an activation barrier higher by 24 kJ·mol⁻¹. Maintaining the jacket temperature at 15±2 °C suppresses the over‑alkylation pathway to <0.8 % of the total peak area, a critical threshold because the tertiary amine impurity co‑elutes with the desired API on preparative chiral chromatography and requires a subsequent counter‑current extraction to remove. When an alternative 2‑(bromomethyl)benzothiazole is employed instead, the primary amination rate increases abruptly at 12 °C, causing the jacket setpoint to be lowered to 5 °C; at that temperature the dimethylacetamide solvent viscosity rises to 2.50 mPa·s, halving the heat transfer coefficient and creating a risk of localized hot‑spots. The chloromethyl derivative therefore permits a more practical cooling strategy using standard brine at −10 °C without entering the solvent’s high‑viscosity regime. The difference is amplified further in continuous flow mode. A Corning® Advanced‑Flow reactor (G1 glass fluidic module, 0.5 mL internal volume per plate) processing a 0.25 M solution of 2‑(chloromethyl)benzothiazole at 1.0 mL·min⁻¹ with a residence time of 45 s yields a steady‑state conversion of 99.2 % with negligible by‑product formation over 8‑hour campaigns. The bromo analog under the same residence time and temperature ramps to 4.5 % of the tertiary amine within 90 min, requiring a mid‑campaign solvent flush. Reports from kilo‑lab operators describe this as a “chlorine‑dependent self‑limiting kinetics” effect that obviates the need for a real‑time feedback loop on the feed pump stroke; instead, a simple mass‑flow controller maintaining the molar ratio is sufficient.

    When Methylbenzothiazole Is No Substitute

    In agrochemical discovery, 2‑methylbenzothiazole has been used to construct certain triazole‑containing fungicide leads, but the absence of a leaving group on the methyl carbon necessitates a directing group strategy or a free‑radical bromination with N‑bromosuccinimide to proceed further. That extra step introduces the handling of azobis(isobutyronitrile) on scale, a substance with self‑accelerating decomposition temperature (SADT) of 50 °C, requiring purpose‑built storage bunkers with blast panels compliant with NFPA 69. By contrast, the chloromethyl derivative enters the synthesis already at the oxidation state required for heteroatom attachment, avoiding radical initiation altogether. A comparative life‑cycle assessment conducted under ISO 14040/14044 for a 1‑tonne annual output of a triazole‑pyrimidine herbicide intermediate indicated a 27 % reduction in total energy demand and a 34 % reduction in CO₂ equivalents when 2‑(chloromethyl)benzothiazole replaced 2‑methylbenzothiazole as the C‑2 building block, primarily because the bromination‑quench‑phase‑separation loop was eliminated. Yet the chloromethyl entity is not universally superior. Under strongly basic conditions, such as those encountered in the generation of alkoxide in DMSO‑d₆ (pD >14), the acidic methylene protons are abstracted, generating a carbanion that reacts with another molecule of the parent compound to form the dimer at a rate that follows second‑order kinetics with a half‑life of 14 min at 25 °C. Therefore, when the downstream transformation requires pre‑formed sodium ethoxide in ethanol, the 2‑(hydroxymethyl)benzothiazole is deliberately selected as the starting material to avoid dimerization, even though it necessitates a subsequent activation step with methanesulfonyl chloride. The process chemistry team documents this decision logic in a control strategy aligned with ICH Q11, retaining the chloromethyl building block exclusively for alkylations conducted at pH 8–10 or in aprotic media. Process development reports filed for a portfolio of hepatitis C NS5B inhibitors highlight another selectivity nuance. When 2‑(chloromethyl)benzothiazole and 2‑(bromomethyl)benzothiazole were each reacted with the same thiol‑terminated prolinol ester, the chloro compound gave an SN2:elimination ratio of 96:4, whereas the bromo derivative gave 82:18. The higher elimination fraction in the latter case generated a vinyl sulfide by‑product that acted as a potent Michael acceptor toward the proline nitrogen of the product, consuming 6 % of the yield per cycle in an autocatalytic sequence. Suppressing this cascade demanded a separate scavenger‑resin hold tank and increased total manufacturing cost by 19 % for the bromo route relative to the chloro route.
    Reactivity Comparison Across 2‑Substituted Benzothiazole Intermediates
    Parameter2‑(Chloromethyl)2‑(Bromomethyl)2‑Mercapto (MBT)
    Primary usage sectorPharma/Agro int.Pharma int.Rubber accelerators
    Typical assay (GC)98.5 %97.0 %96.0 %
    Onset of hydrolysis at 25 °C/60 % RH7 days (0.5 % loss)3 days (1.2 % loss)Not applicable
    Calorimetric ΔHr with NaN₃ (kJ·mol⁻¹)−152−187No reaction
    SN2:Elimination ratio (thiol ester)96:482:18Not applicable
    Residual metal sensitivityPd <10 ppmPd <10 ppmCu <5 ppm
    Storage atmosphereN₂, −20 °CAr, −20 °CAir, ambient
    Regulatory starting material statementICH Q11 compliantICH Q11 compliantNot applicable

    Purity Profile Anchored to a Pharmacopoeial Monograph Framework

    Although a dedicated monograph for 2‑(chloromethyl)benzothiazole does not yet appear in the European Pharmacopoeia, the quality standard is mapped against the general substance monograph 2034 (Substances for pharmaceutical use). The specification includes a test for residual solvents according to Ph.Eur. chapter 2.4.24, limiting the carryover of dichloromethane to ≤600 ppm and dimethylformamide to ≤880 ppm based on a validated headspace GC‑FID method with a Restek Rxi‑624Sil MS column (30 m × 0.25 mm, 1.4 µm). One contract manufacturing organization validated this method across three spiked levels, with a limit of quantification for methylene chloride of 12 ppm, and demonstrated intermediate precision of RSD ≤6.0 %. A separate ion‑chromatography method (Metrohm 930 Compact IC Flex, Metrosep A Supp 5 column, 4.0 mm × 150 mm) quantifies free chloride ion at ≤50 ppm to confirm that no significant hydrolytic degradation has occurred during package and transport. Batches exceeding the free‑chloride threshold are re‑processed through a toluene‑wash procedure to remove ionic contaminants before release, a step that is validated with three consecutive 500 kg demonstration lots. The genomic mutagenicity assessment yielded a negative result in a bacterial reverse mutation test (OECD 471, Salmonella Typhimurium strains TA98, TA100, TA1535, TA1537, at concentrations up to 5,000 µg/plate), with and without S9 metabolic activation prepared from phenobarbital/β‑naphthoflavone‑induced rat liver. An in‑vitro micronucleus test (OECD 487) on TK6 cells following 4‑hour exposure also returned negative at concentrations up to 10 µg·mL⁻¹, a limit dictated by cytotoxicity. These data are provided in a shared technical dossier conforming to the REACH Annex VII–VIII requirements, with the registration number assigned for the 10–100 tonnes per annum band. Downstream users are routinely reminded that the absence of the 2‑(hydroxymethyl) analog in the specification does not imply GRAS status; the compound remains a reactive intermediate and is shipped under GHS07 (exclamation mark) with the H315‑H319‑H335 hazard statements, requiring local exhaust ventilation of ≥0.5 m·s⁻¹ face velocity at manual charging stations. Structural assignment of the key impurities is performed on a Q‑Exactive™ Orbitrap mass spectrometer with resolution set to 140,000 FWHM at 200 m/z. The dimer impurity appears at m/z 313.0132 ([M+H]+), consistent with the molecular formula C₁₆H₁₃ClN₂S₂ (mass error <0.5 ppm). The ring‑chlorinated impurity 2‑(dichloromethyl)benzothiazole gives a distinct isotopic pattern at m/z 217.9591 with an M:M+2 ratio of 100:64, confirming the presence of two chlorine atoms. Routine release testing relies on a simpler HPLC‑UV method at 254 nm, with the Orbitrap method reserved for qualification of reference standards and investigation of out‑of‑trend results in the stability program. An additional precaution relevant to pharmaceutical purchasers is the control of elemental impurities per ICH Q3D. A risk assessment justified the routine monitoring of Class 1 elements As, Cd, Hg, and Pb, and the Class 2A element Co, all by ICP‑MS after microwave digestion. The permitted concentration of lead is set at ≤5 ppm, based on an oral permitted daily exposure of 5 µg·day⁻¹. For the largest clinical dose anticipated from the intermediate’s downstream products, the option 1 analysis yields a concentration limit of 30 ppm; however, the supplier’s tighter internal limit of 5 ppm is driven by a multi‑product facility consideration where dilution factors cannot be guaranteed across all customer applications. Batch records list the instrument model (Agilent 7800 ICP‑MS) and the internal standard used (²⁰⁹Bi at 10 µg·L⁻¹) to permit direct audit by the qualified person of the receiving site. Whereas 2‑mercaptobenzothiazole dominates high‑volume elastomer compounding and 2‑aminobenzothiazole serves as a diazo component in disperse dyes, 2‑(chloromethyl)benzothiazole occupies a niche defined by anhydrous, low‑temperature SN2 chemistry whose product streams are destined for milligram‑ to kilogram‑scale campaigns governed by ICH Q7. The combination of a moderate melting range, a self‑limiting amination exotherm that avoids the need for cryogenic equipment, and a validated impurity control strategy aligned with pharmacopoeial frameworks positions this intermediate as the chemically rational choice when a leaving group must be present at the 2‑position of the benzothiazole nucleus without introducing the hydrolysis lability and elimination channels inherent to the brominated homologue. The documentation package supplied with every 25 kg fibre‑drum shipment includes the batch‑specific certificate of analysis, a residual solvent chromatogram with peak annotations, the mutagenicity summary, and a statement of the storage caveats excerpted above—sufficient for the receiving production chemist to populate the raw‑material section of the master batch record without supplementary inquiry.